Bank of America Reports 5.50% QIAGEN Stake
at www.tipranks.com (Tue, 10-Nov 4:29 PM)
AFM Register Reports T. Rowe Price’s 3.03% QIAGEN Interest
at www.tipranks.com (Tue, 10-Nov 4:29 PM)
T. Rowe Price Group Reports 2.98% Capital Interest in QIAGEN
at www.tipranks.com (Tue, 10-Nov 4:29 PM)
AFM Publishes BlackRock Voting Rights Notification for Qiagen
at www.tipranks.com (Tue, 10-Nov 4:28 PM)
Amundi Notification Reports 3.25% Capital Interest in QIAGEN
at www.tipranks.com (Tue, 10-Nov 4:28 PM)
AFM Register Records UBS Group’s 5.46% QIAGEN Capital Interest
at www.tipranks.com (Tue, 10-Nov 4:28 PM)
AFM Discloses BlackRock Voting-Rights Notification for Qiagen
at www.tipranks.com (Tue, 10-Nov 4:27 PM)
AFM Discloses UBS Group Voting-Rights Notification for Qiagen
at www.tipranks.com (Tue, 10-Nov 4:27 PM)
QIAGEN Reports Q3 Sales Growth, Suspends 2026 Outlook
at www.tipranks.com (Fri, 6-Nov 6:50 AM)
QIAGEN Files Third-Quarter 2026 U.S. GAAP Report
at www.tipranks.com (Fri, 6-Nov 6:49 AM)
QIAGEN Spotlights Tuberculosis Funding Risk as QuantiFERON-TB Tops 160 Million Tests Sold
Market Chameleon (Wed, 14-Oct 7:08 AM)
QIAGEN sets Nov. 6 shareholder vote to add CEO Jonathan M. Pratt to the Managing Board
Market Chameleon (Mon, 21-Sep 9:47 AM)
Market Chameleon (Tue, 25-Aug 9:38 AM)
